CEAP Classification — Chronic Venous Disease
Clinical class (C0–C6) of the CEAP system (Eklöf et al. 2004, revised 2020). Aetiology / Anatomy / Pathophysiology assessed separately. Drives compression, ablation, and ulcer-care decisions.
Score interpretation
→ Reassure. Consider sclerotherapy or laser only for cosmetic concern. Lifestyle (weight, exercise, leg elevation).
→ Duplex US to map venous reflux. If symptomatic and reflux confirmed, NICE CG168 endothermal ablation > foam sclerotherapy > stripping. Compression while awaiting.
→ Urgent vascular referral. Duplex; ABPI before compression. Multilayer compression (40 mmHg) for active ulcer (C6); endothermal ablation of incompetent veins per NICE CG168 to reduce recurrence. Wound care, infection control.
Interpretation bands for the CEAP. Apply clinical judgement and local guidance.
References
Related
Curated clinical cross-links plus same-class fallbacks.
- Methotrexate (Dermatology — Psoriasis) · Disease-Modifying Antirheumatic / Immunosuppressant
- Omalizumab (Dermatology — Chronic Urticaria) · Anti-IgE Monoclonal Antibody
- Acetazolamide (Ménière's Disease) · Carbonic Anhydrase Inhibitor (Diuretic)
- Zinc acetate · Zinc salt (Wilson's disease)
- Fentanyl Transdermal Patch (Elderly Chronic Pain) · Opioid Analgesic — Transdermal Patch
- Morphine Slow-Release (Elderly Chronic Pain) · Opioid Analgesic — Modified-Release Oral
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.